1. STARD3: A Prospective Target for Cancer Therapy
   Kanwal Asif et al, 2021, Cancers CrossRef
2. Comprehensive characterization of stemness-related lncRNAs in triple-negative breast cancer identified a novel prognostic signature related to treatment outcomes, immune landscape analysis and therapeutic guidance: a silico analysis with in vivo experiments
   Min Zhang et al, 2024, Journal of Translational Medicine CrossRef
3. Expression of lipid transport‐associated genes in lipid‐deprived cancer cells
   Naila Shoaib et al, 2021, Genes to Cells CrossRef
4. Correlation analysis of lipid metabolism genes with the immune microenvironment in gastric cancer and the construction of a novel gene signature
   Yaqi Li et al, 2022, Clinical and Translational Oncology CrossRef
5. Correlation between serum lipid levels and endocrine resistance in patients with ER-positive breast cancer
   Hong Sun et al, 2023, Medicine CrossRef
6. Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients
   Jin-Rong He et al, 2023, Aging CrossRef
7. SREBF2–STARD4 axis confers sorafenib resistance in hepatocellular carcinoma by regulating mitochondrial cholesterol homeostasis
   Xuetian Yue et al, 2023, Cancer Science CrossRef
8. A signature based on circadian rhythm-associated genes for the evaluation of prognosis and the tumour microenvironment in HNSCC
   Changqian Wang et al, 2024, Scientific Reports CrossRef
9. Exploring Amanita muscaria (L.) Lam.: Cytotoxic, proapoptotic and antiferroptotic effect of acetone extract on JAR choriocarcinoma cell line
   Sara Milojević et al, 2024, Kragujevac Journal of Science CrossRef